Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hearne Michael S
Relationship:   Chief Financial Officer
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   2,620    

Indirect Shares

   12,767,435      
Direct Value   $7,465,690    

Indirect Value

   $36,380,806,033      
Total Shares   12,770,055      
Total Value   $36,388,271,723      


Odonate Therapeutics Inc $7,465,690 Odonate Therapeutics Inc $7,465,690
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    20   
    3    

     Stock price went up :
    10   
    0    
     Stock price went down :
    10   
    3    
   
     Gain/Loss Ratio :
   0.0   
   -3.0   
     Percentage Gain/Loss :
   -17.1%
 -97.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Odonate Therapeutics Inc ODT Chief Financial Officer 2021-03-15 2,620 2021-11-19 12,767,435    Premium*  
            La Jolla Pharmaceutical Co LJPC Chief Financial Officer 2022-08-22 0 2022-08-22 0    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-27 4 B $12.03 $120,315 I/I 10,000 12,892,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-17 4 B $26.20 $269,231 I/I 10,042 13,284,688 1.99 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2022-08-22 4 D $6.23 $63,459 D/D (10,186) 0 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-06 4 B $14.62 $153,573 I/I 10,500 12,752,838 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-09-29 4 B $13.85 $150,698 I/I 10,882 15,238,782 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-18 4 B $14.13 $167,189 I/I 11,704 12,822,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-12 4 B $15.65 $228,946 I/I 14,550 12,782,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-03 4 B $22.16 $343,904 I/I 15,286 13,101,324 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-17 4 B $14.51 $268,612 I/I 18,296 12,810,634 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-14 4 B $24.95 $464,294 I/I 18,608 13,274,646 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-21 4 B $12.27 $255,828 I/I 20,000 12,852,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-28 4 B $12.04 $253,863 I/I 20,000 12,912,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-07 4 B $26.31 $526,220 I/I 20,000 13,256,038 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-18 4 B $26.89 $574,020 I/I 21,350 13,306,038 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-26 4 B $12.09 $368,287 I/I 30,000 12,882,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-31 4 B $13.42 $460,929 I/I 33,700 12,946,038 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-04 4 B $24.92 $970,772 I/I 38,950 13,140,274 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-05 4 B $25.14 $1,020,541 I/I 39,456 13,179,730 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-03-07 4 B $16.56 $681,733 I/I 40,000 12,986,038 1.99 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-08-12 4 B $3.47 $150,820 I/I 43,513 8,738,987 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-06 4 B $27.56 $1,561,237 I/I 56,308 13,236,038 1.99 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2021-06-01 4 B $4.29 $263,931 I/I 59,092 10,049,224 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-12-21 4 B $14.58 $905,767 I/I 62,144 15,300,926 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-09-04 4 B $3.82 $258,359 I/I 67,552 9,194,673 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-12-22 4 B $14.58 $1,107,587 I/I 74,502 15,375,428 1.99 %
  145  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us